GRTXD — Galera Therapeutics, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1563577 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -1,655,000 | -1,606,000 | 6,164,000 | 5,500,000 | 1,141,000 |
| Dec 2025 | 0 | — | -1,508,000 | 153,104,000 | 7,196,000 | 6,375,000 | 645,000 |
| Sep 2025 | 0 | — | -1,436,000 | -1,388,000 | 5,002,000 | 4,473,000 | 154,224,000 |
| Jun 2025 | 0 | — | -1,135,000 | -1,075,000 | 6,048,000 | 5,230,000 | 153,993,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,686,000
Investing CF
$3,450,000
Financing CF
$0
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.03
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
$-308,920,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-5,734,000
Pretax Income TTM
$149,035,000
Interest Exp TTM
$0
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -6,042,000 | 149,049,000 | 7,196,000 | 645,000 | — | -6,049,000 |
| Dec 2024 | 0 | -14,153,000 | -18,957,000 | 10,101,000 | 153,770,000 | — | -12,145,000 |
| Dec 2023 | 0 | -46,951,000 | -59,082,000 | 26,141,000 | 157,326,000 | — | -44,848,000 |
| Dec 2022 | 0 | -51,226,000 | -62,222,000 | 44,036,000 | 153,217,000 | — | -43,426,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.07T | $1197.53 | — |
| JNJ | JOHNSON & JOHNSON | $640.91B | $265.95 | — |
| ABBV | AbbVie Inc. | $453.91B | $256.91 | — |
| MRK | Merck & Co., Inc. | $322.95B | $130.76 | — |
| NVS | NOVARTIS AG | $296.72B | $156.11 | — |
Recent Insider Activity
No insider activity indexed for this ticker.